Resveratrol modulates RTX toxin-induced cytotoxicity through interference in adhesion and toxin production

European Journal of Pharmacology

Volumn 642, Issue 1-3, 2010, Pages 163-168

  Kim, Jong Ro ^a   Cha, Mi Hye ^a   Oh, Dool Ri ^a   Oh, Won Keun ^b   Rhee, Joon Haeng ^c   Kim, Young Ran ^a,c  

^a Dongshin University   (South Korea)

^b Chosun University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Adhesion; Cytotoxicity; Resveratrol; RTX toxin; Vibrio vulnificus

Indexed keywords

BACTERIAL TOXIN; RESVERATROL; MESSENGER RNA; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CELL ADHESION; CELL DAMAGE; CELL MOTILITY; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; HELA CELL; HOST CELL; HOST PARASITE INTERACTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INFECTION PREVENTION; MICROBIAL ADHESION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXIN SYNTHESIS; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION; ANIMAL; BACTERIUM ADHERENCE; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; METABOLISM; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; SEPSIS; TOXICITY; VIBRIO INFECTIONS;

ANIMALS; BACTERIAL ADHESION; BACTERIAL TOXINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, BACTERIAL; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MOVEMENT; RNA, MESSENGER; SEPSIS; STILBENES; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 77954623645     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.037     Document Type: Article

References (38)

1. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
2. Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. (Phila Pa) 2009, 2:409-418.
3. Casadevall A., Pirofski L.A. Microbial virulence results from the interaction between host and microorganism. Trends Microbiol. 2003, 11:157-158. author reply 158-159.
4. Choi M.H., Park R.Y., Sun H.Y., Kim C.M., Bai Y.H., Lee S.E., Kim S.Y., Kim Y.R., Rhee J.H., Shin S.H. Suppression and inactivation of Vibrio vulnificus hemolysin in cirrhotic ascites, a human ex vivo experimental system. FEMS Immunol. Med. Microbiol. 2006, 47:226-232.
5. Das D.K., Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv. 2006, 6:36-47.
6. Dhakal B.K., Lee W., Kim Y.R., Choy H.E., Ahnn J., Rhee J.H. Caenorhabditis elegans as a simple model host for Vibrio vulnificus infection. Biochem. Biophys. Res. Commun. 2006, 346:751-757.
7. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., Russell R.E., Barnes P.J. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L774-L783.
8. Elliott P.J., Jirousek M. Sirtuins: novel targets for metabolic disease. Curr. Opin. Investig. Drugs 2008, 9:371-378.
9. Giron J.A., Torres A.G., Freer E., Kaper J.B. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol. Microbiol. 2002, 44:361-379.
10. Heithoff D.M., Conner C.P., Hanna P.C., Julio S.M., Hentschel U., Mahan M.J. Bacterial infection as assessed by in vivo gene expression. Proc. Natl Acad. Sci. USA 1997, 94:934-939.
11. Hung L.M., Su M.J., Chu W.K., Chiao C.W., Chan W.F., Chen J.K. The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br. J. Pharmacol. 2002, 135:1627-1633.
12. Issuree P.D., Pushparaj P.N., Pervaiz S., Melendez A.J. Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. FASEB J. 2009, 23:2412-2424.
13. Iyori M., Kataoka H., Shamsul H.M., Kiura K., Yasuda M., Nakata T., Hasebe A., Shibata K. Resveratrol modulates phagocytosis of bacteria through an NF-kappaB-dependent gene program. Antimicrob. Agents Chemother. 2008, 52:121-127.
14. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
15. Kang S.S., Cuendet M., Endringer D.C., Croy V.L., Pezzuto J.M., Lipton M.A. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg. Med. Chem. 2009, 17:1044-1054.
16. Kim S.Y., Lee S.E., Kim Y.R., Kim C.M., Ryu P.Y., Choy H.E., Chung S.S., Rhee J.H. Regulation of Vibrio vulnificus virulence by the LuxS quorum-sensing system. Mol. Microbiol. 2003, 48:1647-1664.
17. Kim Y.R., Lee S.E., Kim C.M., Kim S.Y., Shin E.K., Shin D.H., Chung S.S., Choy H.E., Progulske-Fox A., Hillman J.D., Handfield M., Rhee J.H. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect. Immun. 2003, 71:5461-5471.
18. Kim Y.R., Lee S.E., Kook H., Yeom J.A., Na H.S., Kim S.Y., Chung S.S., Choy H.E., Rhee J.H. Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell. Microbiol. 2008, 10:848-862.
19. Kim Y.R., Rhee J.H. Flagellar basal body flg operon as a virulence determinant of Vibrio vulnificus. Biochem. Biophys. Res. Commun. 2003, 304:405-410.
20. Kundu J.K., Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269:243-261.
21. Lee B.C., Kim S.H., Choi S.H., Kim T.S. Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus. Immunology 2005, 115:506-515.
22. Lee S.E., Kim S.Y., Jeong B.C., Kim Y.R., Bae S.J., Ahn O.S., Lee J.J., Song H.C., Kim J.M., Choy H.E., Chung S.S., Kweon M.N., Rhee J.H. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect. Immun. 2006, 74:694-702.
23. Liu M., Alice A.F., Naka H., Crosa J.H. The HlyU protein is a positive regulator of rtxA1, a gene responsible for cytotoxicity and virulence in the human pathogen Vibrio vulnificus. Infect. Immun. 2007, 75:3282-3289.
24. Liu M., Naka H., Crosa J.H. HlyU acts as an H-NS antirepressor in the regulation of the RTX toxin gene essential for the virulence of the human pathogen Vibrio vulnificus CMCP6. Mol. Microbiol. 2009, 72:491-505.
25. Lu C.C., Lai H.C., Hsieh S.C., Chen J.K. Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats. J. Leukoc. Biol. 2008, 83:1028-1037.
26. Miller V.L., Mekalanos J.J. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 1988, 170:2575-2583.
27. Milton D.L., O'Toole R., Horstedt P., Wolf-Watz H. Flagellin A is essential for the virulence of Vibrio anguillarum. J. Bacteriol. 1996, 178:1310-1319.
28. Oliver J.D. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol. Infect. 2005, 133:383-391.
29. Osicka R., Prochazkova K., Sulc M., Linhartova I., Havlicek V., Sebo P. A novel "clip-and-link" activity of repeat in toxin (RTX) proteins from gram-negative pathogens. Covalent protein cross-linking by an Asp-Lys isopeptide bond upon calcium-dependent processing at an Asp-Pro bond. J. Biol. Chem. 2004, 279:24944-24956.
30. Pirola L., Frojdo S. Resveratrol: one molecule, many targets. IUBMB Life 2008, 60:323-332.
31. Reddy G.P., Hayat U., Abeygunawardana C., Fox C., Wright A.C., Maneval D.R., Bush C.A., Morris J.G. Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J. Bacteriol. 1992, 174:2620-2630.
32. Roy K., Hilliard G.M., Hamilton D.J., Luo J., Ostmann M.M., Fleckenstein J.M. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature 2009, 457:594-598.
33. Shankar S., Singh G., Srivastava R.K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 2007, 12:4839-4854.
34. Tacket C.O., Brenner F., Blake P.A. Clinical features and an epidemiological study of Vibrio vulnificus infections. J. Infect. Dis. 1984, 149:558-561.
35. Wang W.B., Lai H.C., Hsueh P.R., Chiou R.Y., Lin S.B., Liaw S.J. Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. J. Med. Microbiol. 2006, 55:1313-1321.
36. Welch R.A. RTX toxin structure and function: a story of numerous anomalies and few analogies in toxin biology. Curr. Top. Microbiol. Immunol. 2001, 257:85-111.
37. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
38. Zaidi S.F., Ahmed K., Yamamoto T., Kondo T., Usmanghani K., Kadowaki M., Sugiyama T. Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol. Pharm. Bull. 2009, 32:1931-1935.